Constar launches single-source packaging for private label contact lenses
Gansu Constar Technology Group says it is bringing blister foil, cartons, leaflets, inserts and starter kits under one production roof for brands launching contact lens lines. The move is meant to cut supplier handoffs, reduce artwork mismatches and speed private label launches.
Why it matters: - Private label contact lens brands often lose time when packaging work is split across multiple suppliers. - Constar’s single-source model is meant to shorten lead times and reduce errors between the foil, carton, leaflet and finished kit. - The change could help smaller brands launch shelf-ready products with fewer handoffs.
What happened: - Gansu Constar Technology Group Co., Ltd. announced a single-source packaging programme for private label contact lens brands. - The programme consolidates printed blister foil, retail cartons, leaflets, inserts and co-branded starter kits under one production roof. - Constar said the offer is designed for brands launching their own contact lens lines.
The details: - The programme covers primary packaging, including printed blister foil made to a brand’s own artwork. - It also covers secondary packaging, including the retail carton, patient leaflet and any insert. - Kit assembly includes multi-purpose solution, eye wash and co-branded starter kits. - Constar said first orders can ship as shelf-ready retail units instead of lenses that still need third-party packaging. - Artwork is reviewed against destination-market requirements before a print run is released. - Label copy is treated as a regulatory artefact, not a design choice. - Manufacturer name and address, device classification, the referenced clearance or certificate, storage conditions and language requirements vary by jurisdiction. - In the United States, soft contact lenses intended for daily wear are Class II medical devices under 21 CFR 886.5925. - Constar serves brand owners, distributors and e-commerce sellers through a private label contact lens manufacturing model. - The company covers pattern selection, lens material, optical parameters and packaging within a single programme. - Buyers can use Constar’s 12-point manufacturer scorecard to compare claims against documents they can request and verify. - Production runs are completed in 30 to 45 days regardless of order size. - The end-to-end window from brief to delivery is about 55 days on catalogue patterns. - Minimum order quantities are set per SKU rather than per order. - The company said the structure is meant to support a first order from an emerging brand, with the unit basis confirmed in writing before commitment. - A spokesperson said packaging is where private label projects quietly lose weeks and that consolidating the package changes the critical path, not just the invoice.
Between the lines: - The packaging programme turns a fragmented supply chain into a more controlled workflow. - That matters because contact lens packaging is tied to regulatory content as well as branding. - The move also signals that speed and compliance are being packaged as part of the manufacturing offer, not handled later by another vendor.
What's next: - Brand owners can request a packaging consultation and artwork review at Constar’s website. - Brand owners can also contact the international business team directly. - Constar says it operates six production facilities across Gansu and Hunan provinces with a combined capacity of 15 million lenses per month. - The company holds FDA 510(k) clearance, CE 0197 marking and ISO 13485 certification, plus national registrations in Australia, Saudi Arabia, Indonesia, Thailand and Vietnam. - In its company profile, Constar says it serves partners in more than 40 countries.
The bottom line: - Constar is betting that faster packaging, fewer handoffs and built-in regulatory review will make private label contact lens launches easier to execute.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
Indonesia Healthcare Press
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.